Code
|
90366
|
MA number
|
EU/1/99/126/005
|
Product Form:
|
plv iol 24x25 mg + 24x1 ml solv. (liek.inj.skl.+striek.inj.napl.skl.)
|
MA Status:
|
E - Valid centralised marketing authorisation
|
Type of procedure:
|
EU
|
MAH, country:
|
Pfizer Europe MA EEIG, Belgium
|
Therapeutic Class:
|
29 - ANTIRHEUMATICA, ANTIPHLOGISTICA, ANTIURATICA
|
ATC:
|
L |
ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS |
L04 |
Immunosuppressants |
L04A |
Immunosuppressants |
L04AB |
Tumor necrosis factor alpha (TNF-alpha) inhibitors |
L04AB01 |
Etanercept |
|
Shelf life:
|
48 |
Route of admin.:
|
Subcutaneous use
|